Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biodroga is a Canadian-based contract development and manufacturing organization (CDMO) specializing in the nutraceutical and natural health product sectors. Founded in 1988 and later acquired by Lycored, the company provides comprehensive services ranging from custom formulation to large-scale production of dietary supplements. Their core expertise lies in complex delivery systems for omega-3 oils, probiotics, and botanical extracts. Biodroga operates GMP-compliant facilities and serves a global clientele in the functional food and wellness industries. The company is recognized for its ability to handle sensitive ingredients and provide science-backed solutions for brand owners. Since its acquisition, Biodroga has served as a strategic North American hub for advanced nutrient delivery technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biodroga.